Oppenheimer's Takeaway from Ingevity Corp (NGVT) Management Meetings

Oppenheimer analyst Ian Zaffino reiterated an Outperform rating and $85.00 price target on Ingevity Corp (NYSE: NGVT) after hosting management for a series of investor meetings. Management believes it can grow topline MSD/HSD organically over the next 3–5 years. To do so, it will increase utilization rates in Chemicals through alternative feedstocks, make needed investments in CAPA, capitalize on the increased demand created by new Auto regulations and pursue Methane-capture.

The analyst stated "Over the next five years, we estimate NGVT will generate over $1B of cash, which could be used for tuck-in M&A, modest growth capex (e.g., $100–150M), debt paydown and share repurchases. Separately, NGVT announced the appointment of Mary Dean Hall as EVP and CFO, effective 4/19. Hall was most recently the SVP, CFO and Treasurer of Quaker Houghton and has deep experience in chemicals and industrials."

For an analyst ratings summary and ratings history on Ingevity Corp click here. For more ratings news on Ingevity Corp click here.

Shares of Ingevity Corp closed at $74.04 yesterday.

You May Also Be Interested In

• Ricoh Company (7752:JP) (RICOY) PT Raised to JPY1,500 at JPMorgan
• Sika AG (SIKA:SW) (SKFOF) PT Raised to CHF295 at Berenberg
• Tesla (TSLA) PT Raised to $900 at Morgan Stanley Ahead of Q1 Results